Exploration of Postoperative Adjuvant Therapy for HCC Patients With Positive TB

NCT07160361 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Hepatocellular

Interventions

DRUG: Lenvatinib + losartan

Sponsor

Second Affiliated Hospital of Xi'an Jiaotong University

Collaborators

[object Object]
[object Object]
[object Object]